Articles dans des revues avec comité de lecture (396)
  1. 1. Lalami, Y., Garcia, C., Flamen, P., Ameye, L., Paesmans, M., & Awada, A. (2015). A Phase II trial evaluating the efficacy of sorafenib (BAY 43-9006) and correlating early FDG PET-CT response to outcome in patients with recurrent and/or metastatic head and neck cancer. Head & neck. doi:10.1002/hed.23898
  2. 2. Demedts, I., Van Meerbeeck, J., Berghmans, T., & Awada, A. (2024). Le Groupe de Travail sur le CB d’All.Can Belgium dans les starting-blocks. Revue médicale de Bruxelles, 45(2).
  3. 3. Kristeleit, R., Leary, A., Delord, J. P., Moreno, V., Oaknin, A., Castellano, D., Shappiro, G. G., Fernández, C., Kahatt, C., Alfaro, V., Siguero, M., Rueda, D., Zeaiter, A., Awada, A., Santaballa, A., Zaman, K., Sehouli, J., & Subbiah, V. (2023). Lurbinectedin in patients with pretreated endometrial cancer: results from a phase 2 basket clinical trial and exploratory translational study. Investigational new drugs, 41(5), 677-687. doi:10.1007/s10637-023-01383-2
  4. 4. Schöffski, P., Machiels, J. P., Rottey, S., Sadrolhefazi, B., Musa, H., Marzin, K., & Awada, A. (2023). Phase Ia dose-escalation trial with the BET protein inhibitor BI 894999 in patients with advanced or metastatic solid tumours. European journal of cancer, 191, 112987. doi:10.1016/j.ejca.2023.112987
  5. 5. Gombos, A., Goncalves, A., Curigliano, G., Bartsch, R., Kyte, J. A., Ignatiadis, M., & Awada, A. (2023). How I treat endocrine-dependent metastatic breast cancer. ESMO Open, 8(2), 100882. doi:10.1016/j.esmoop.2023.100882
  6. 6. Castelo-Branco, L., Morgan, G., Prelaj, A., Scheffler, M., Canhão, H. C. D. M. H., Van Meerbeeck, J. P. A. M. J., & Awada, A. (2023). Challenges and knowledge gaps with immune checkpoint inhibitors monotherapy in the management of patients with non-small-cell lung cancer: a survey of oncologist perceptions. ESMO Open, 8(1), 100764. doi:10.1016/j.esmoop.2022.100764
  7. 7. Gascon, P., Awada, A., Karihtala, P., Lorenzen, S., & Minichsdorfer, C. (2023). Optimal use of granulocyte colony-stimulating factor prophylaxis to improve survival in cancer patients receiving treatment: An expert view. Wiener Klinische Wochenschrift. doi:10.1007/s00508-023-02300-6
  8. 8. Marta, G. N., Molinelli, C., Debien, V., Martins-Branco, D., Aftimos, P., de Azambuja, E., & Awada, A. (2023). Antibody–drug conjugates: the evolving field of targeted chemotherapy for breast cancer treatment. Therapeutic advances in medical oncology, 15. doi:10.1177/17588359231183679
  9. 9. Spira, A., Awada, A., Isambert, N., Lorente, D., Penel, N., Zhang, H.-Y., Ojalvo, L., Hicking, C., Rolfe, A. P., Ihling, C., Dussault, I., Locke, G., & Borel, C. (2022). Identification of HMGA2 as a predictive biomarker of response to bintrafusp alfa in a phase 1 trial in patients with advanced triple-negative breast cancer. Frontiers in oncology, 12, 981940. doi:10.3389/fonc.2022.981940
  10. 10. Kehagias, P., Kindt, N., Krayem, M., Najem, A., Agostini, G., Acedo Reina, E., Bregni, G., Sclafani, F., Journé, F., Awada, A., Ghanem, G. E., & Hendlisz, A. (2022). Regorafenib Induces Senescence and Epithelial-Mesenchymal Transition in Colorectal Cancer to Promote Drug Resistance. Cells, 11(22), 3663. doi:10.3390/cells11223663
  11. 11. Kim, T. W., Burris, H. H., de Miguel Luken, M. J., Pishvaian, M. M., Bang, Y. J., Gordon, M., Awada, A., Camidge, D. R., Hodi, F. S., McArthur, G. A., Miller, W. W., Cervantes, A., Chow, L. Q. M. L., Lesokhin, A. A., Rutten, A., Sznol, M., Rishipathak, D., Chen, S. C., Stefanich, E., Pourmohamad, T., Anderson, M., Kim, J., Huseni, M., Rhee, I., & Siu, L. L. Y. L. (2022). First-In-Human Phase I Study of the OX40 Agonist MOXR0916 in Patients with Advanced Solid Tumors. Clinical cancer research, 28(16), 3452-3463. doi:10.1158/1078-0432.CCR-21-4020
  12. 12. Marin, J., Journé, F., Ghanem, G. E., Awada, A., & Kindt, N. (2022). Cytokine Landscape in Central Nervous System Metastases. Biomedicines, 10(7), 1537. doi:10.3390/biomedicines10071537
    13. << Précédent 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36
    37     38 39 Suivant >>